CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
CTO crossing in femoropopliteal arteries CONNECT IIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01537302
NCT01537302N/ACompleted
CompareCT.gov

A Non-randomized Study of the Avinger Ocelot System Used to Cross Chronic Total Occlusions in the Superficial Femoral and Popliteal Arteries

Avinger, Inc.·interventional·Posted Feb 23, 2012·Updated Mar 22, 2021

In Brief

A clinical study evaluating CTO crossing in femoropopliteal arteries CONNECT II for Total Atherosclerotic Occlusion of Femoral Artery. Completed, enrolled 100 participants across 17 sites in 3 countries.

Detailed Summary

Evaluation of the safety and effectiveness of the Ocelot System to provide OCT-assisted orientation while simultaneously crossing totally occluded femoropopliteal arteries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTotal Atherosclerotic Occlusion of Femoral Artery
CountriesGermany, Italy, United States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 23, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.4 years ago

Interventions

CTO crossing in femoropopliteal arteries CONNECT IIdevice

CTO crossing in femoropopliteal arteries using the Ocelot System